Literature DB >> 10751417

Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation.

C L Venable1, E U Frevert, Y B Kim, B M Fischer, S Kamatkar, B G Neel, B B Kahn.   

Abstract

Previous studies suggested that protein-tyrosine phosphatase 1B (PTP1B) antagonizes insulin action by catalyzing dephosphorylation of the insulin receptor (IR) and/or other key proteins in the insulin signaling pathway. In adipose tissue and muscle of obese humans and rodents, PTP1B expression is increased, which led to the hypothesis that PTP1B plays a role in the pathogenesis of insulin resistance. Consistent with this, mice in which the PTP1B gene was disrupted exhibit increased insulin sensitivity. To test whether increased expression of PTP1B in an insulin-sensitive cell type could contribute to insulin resistance, we overexpressed wild-type PTP1B in 3T3L1 adipocytes using adenovirus-mediated gene delivery. PTP1B expression was increased approximately 3-5-fold above endogenous levels at 16 h, approximately 14-fold at 40 h, and approximately 20-fold at 72 h post-transduction. Total protein-tyrosine phosphatase activity was increased by 50% at 16 h, 3-4-fold at 40 h, and 5-6-fold at 72 h post-transduction. Compared with control cells, cells expressing high levels of PTP1B showed a 50-60% decrease in maximally insulin-stimulated tyrosyl phosphorylation of IR and insulin receptor substrate-1 (IRS-1) and phosphoinositide 3-kinase (PI3K) activity associated with IRS-1 or with phosphotyrosine. Akt phosphorylation and activity were unchanged. Phosphorylation of p42 and p44 MAP kinase (MAPK) was reduced approximately 32%. Overexpression of PTP1B had no effect on basal, submaximally or maximally (100 nm) insulin-stimulated glucose transport or on the EC(50) for transport. Our results suggest that: 1) insulin stimulation of glucose transport in adipocytes requires </=45% of maximal tyrosyl phosphorylation of IR or IRS-1 and <50% of maximal activation of PI3K, 2) a novel PI3K-independent pathway may play a role in insulin-induced glucose transport in adipocytes, and 3) overexpression of PTP1B alone in adipocytes does not impair glucose transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751417     DOI: 10.1074/jbc.M908392199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Expression of a prenylation-deficient Rab4 inhibits the GLUT4 translocation induced by active phosphatidylinositol 3-kinase and protein kinase B.

Authors:  M Cormont; N Gautier; K Ilc; Y le Marchand-Brustel
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

2.  Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway.

Authors:  Thangiah Geetha; Paul Langlais; Michael Caruso; Zhengping Yi
Journal:  J Endocrinol       Date:  2012-06-22       Impact factor: 4.286

3.  Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K.

Authors:  Amélie Pelletier; Annie Tardif; Marie-Hélène Gingras; Jean-Louis Chiasson; Lise Coderre
Journal:  Mol Cell Biochem       Date:  2006-09-08       Impact factor: 3.396

4.  Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP.

Authors:  Sandra Galic; Manuela Klingler-Hoffmann; Michelle T Fodero-Tavoletti; Michelle A Puryer; Tzu-Ching Meng; Nicholas K Tonks; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

5.  Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.

Authors:  Janice M Zabolotny; Young-Bum Kim; Laura A Welsh; Erin E Kershaw; Benjamin G Neel; Barbara B Kahn
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

6.  SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.

Authors:  Takeshi Yoshizaki; Jill C Milne; Takeshi Imamura; Simon Schenk; Noriyuki Sonoda; Jennie L Babendure; Juu-Chin Lu; Jesse J Smith; Michael R Jirousek; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

7.  Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).

Authors:  Philomena Alapatt; Fangjian Guo; Susan M Komanetsky; Shuping Wang; Jinjin Cai; Ashot Sargsyan; Eduardo Rodríguez Díaz; Brandon T Bacon; Pratik Aryal; Timothy E Graham
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

8.  Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway.

Authors:  Naoko Sasaki-Suzuki; Kiyoshi Arai; Tomomi Ogata; Kouhei Kasahara; Hideyuki Sakoda; Kazuhiro Chida; Tomoichiro Asano; Jeffrey E Pessin; Fumihiko Hakuno; Shin-Ichiro Takahashi
Journal:  J Biol Chem       Date:  2009-01-02       Impact factor: 5.157

9.  Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats.

Authors:  Paty Karoll Picardi; Vivian Cristine Calegari; Patricia Oliveira Prada; Patrícia de Oliveira Prada; Juliana Contin Moraes; Eliana Araújo; Maria Cristina Cintra Gomes Marcondes; Miriam Ueno; José Barreto Campello Carvalheira; Licio Augusto Velloso; Mario José Abdalla Saad
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

10.  Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone.

Authors:  M Irfan Ali; Pimonrat Ketsawatsomkron; Eric J Belin de Chantemele; James D Mintz; Kenjiro Muta; Christina Salet; Stephen M Black; Michel L Tremblay; David J Fulton; Mario B Marrero; David W Stepp
Journal:  Circ Res       Date:  2009-09-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.